Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
boulder/denver blog main
boulder/denver top stories
crispr
6
×
detroit blog main
detroit top stories
ipo
6
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
6
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
fda
indiana blog main
indiana top stories
cancer
novartis
biogen
deals
editas medicine
eli lilly
gene editing
glaxosmithkline
medical devices
startups
What
bio
roundup
life
moves
science
ceo
crispr
ipo
millions
new
therapeutics
week
years
acquisitions
allogene
announced
bails
becker
big
billions
black
bosley's
bosley’s
brand
bridge
bridgebio
bucks
cancer
capital
car
cas
collabs
companies
continue
covid
crime
daniel
deal
debut
departure
Language
unset
Current search:
crispr
×
biotech
×
ipo
×
" san diego top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More